Skip to main content
SpringerLink
Log in
Book cover

Biochemical Neurology pp 129–192Cite as

Disorders of the metabolism of larger molecules

  • Chapter

  • 19 Accesses

Abstract

Neural tissue contains a variety of large molecules which have a number of known biological functions, as well as often providing a basis for cell structure. Proteins function both as enzymes and as receptors for the attachment of other molecules and the subsequent transduction of this attachment into further biochemical events; nucleic acids convey genetic information; carbohydrates (as glycogen) are stores of energy, and lipids appear to have structural, permeability (membrane) and insulating functions (e.g. myelin). In addition, neural tissue contains complex macromolecules formed from admixture of protein, carbohydrate and lipid components, e.g. lipoproteins, glycoproteins, glycos-aminoglycans (mucopolysaccharides) and glycolipids. Individual macro-molecules may exist in cells bonded into even larger and more complex macromolecule aggregates. For convenience, biological macromolecules are often considered in terms of their individual components which are chemically stable enough to be able to exist in isolation after preliminary separation procedures. Such components are themselves usually comparatively large molecules.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Norton, W. T. (1976). Formation, structure and biochemistry of myelin. In Siegel, G. J., Albers, R. W., Kratzmen, R. and Agranoff, B. W. (eds.) Basic Neurochemistry, 2nd Edn., pp. 74–99. (Boston: Little, Brown & Co.)

    Google Scholar 

  2. Mcllwain, H. and Bachelard, H. S. (1971). Biochemistry and the Central Nervous System. 4th Edn. (Edinburgh: Churchill-Livingstone)

    Google Scholar 

  3. Stoffel, W. (1967). The chemistry of mammalian lipids. In Schettler, G. (ed.) Lipids and Lipidoses, pp. 1–39. (Berlin: Springer)

    Google Scholar 

  4. Rouser, G. and Yamamoto, A. (1969). Lipids. In Lathja, A. (ed.) Handbook of Neurochemistry. Vol. 1, pp. 121–169. (New York: Plenum Press)

    Google Scholar 

  5. Awasthi, Y. C. and Srivastava, S. K. (1980). Structure, function and metabolism of glycosphin-golipids. In Kumar, S. (ed.) Biochemistry of Brain, pp. 1–20. (Oxford: Pergamon Press)

    Google Scholar 

  6. Max, S. R., MacLaren, N. K., Brady, R. O., Bradley, R. M., Rennels, M. B., Tanaka, J., Garcia, J. H. and Cornblath, M. (1974). GM3 (hematoside) sphingolipodystrophy. N. Engl. J. Med., 291, 929–931

    CAS  PubMed  Google Scholar 

  7. Schaumburg, H. H., Powers, J. M., Raine, C. S., Suzuki, K. and Richardson, E. P. Jr. (1975). Adrenoleucodystrophy. A clinical and pathological study of 17 cases. Arch. Neurol., 32, 577–591.

    CAS  PubMed  Google Scholar 

  8. O’Neill, B. P., Marmion, L. C. and Feringa, E. R. (1981). The adrenoleukomyeloneuropathy complex: expressions in four generations. Neurology, 31, 151–156

    PubMed  Google Scholar 

  9. Igarashi, M., Schaumburg, H. H., Powers, J., Kishimoto, Y., Kolodney, E. and Suzuki, K. (1976). Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem., 26, 851–860

    CAS  PubMed  Google Scholar 

  10. Menkes, J. H. and Corbo, L. M. (1977). Adrenoleucodystrophy. Accumulation of cholesterol esters with very long chain fatty acids. Neurology, 27, 926–932

    Google Scholar 

  11. Molzer, B., Bernheimer, H., Budka, H., Pilz, P. and Toifl, K.(1981). Accumulation of very long chain fatty acids is common to 3 variants of adrenoleukodystrophy (ALD). ‘Classical’ ALD, atypical ALD (female patient) and adrenomyeloneuropathy. J. Neurol. Sci., 51, 301–310

    CAS  PubMed  Google Scholar 

  12. Ogino, T. and Suzuki, K. (1981). Specificities of human and rat brain enzymes of cholesterol ester metabolism towards very long chain fatty acids: implication for biochemical pathogenesis of adrenoleucodystrophy. J. Neurochem., 36, 776–779

    CAS  PubMed  Google Scholar 

  13. Yahara, S., Moser, H. W., Kolodny, E. H. and Kishimoto, Y. (1980). Reverse phase high-performance liquid chromatography of cerebrosides, sulfatides and ceramides: microanalysis of homolog composition without hydrolysis and application to cerebroside analysis in peripheral nerves of adrenoleucodystrophy patients. J. Neurochem., 34, 694–699

    CAS  PubMed  Google Scholar 

  14. Schaumburg, H. H., Powers, J. M., Raine, C. S., Spencer, P. S., Griffin, J. W., Prineas, J. W. and Boehme, D. M. (1977). Adrenomyeloneuropathy: a probable variant of adrenoleucodystrophy. II. General pathologic, neuropathology, and biochemical aspects. Neurology, 27, 1114–1119

    CAS  PubMed  Google Scholar 

  15. Manz, H. J., Schuelein, M., McCullogh, D. C., Kishimoto, Y. and Eiben, R. M. (1980). New phenotypic variant of adrenoleucodystrophy. Pathologic, ultrastructural and biochemical study in two brothers. J. Neurol. Sci., 45, 245–260

    CAS  PubMed  Google Scholar 

  16. Griffin, J. W., Goren, E., Schaumburg, H., Engel, W. R. and Loriaux, L. (1977). Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology, 27, 1107–1113

    CAS  PubMed  Google Scholar 

  17. Bourre, J. M., Bornhofen, J. H., Araoz, C. A., Daudu, O. and Baumann, N. A. (1978). Pelizaeus-Merzbacher disease: brain lipid and fatty composition. J. Neurochem., 30, 719–727

    CAS  PubMed  Google Scholar 

  18. Witter, B., Debuch, H. and Klein, H. (1980). Lipid investigation of central and peripheral nervous system in connatal Pelizaeus-Merzbacher’s disease. J. Neurochem., 34, 957–962

    CAS  PubMed  Google Scholar 

  19. Kahlke, W. (1967). A-β-lipoproteinemia (Bassen-Kornzweig syndrome). In Schettler, G. (ed.) Lipids and Lipidoses, pp. 382–400. (Berlin: Springer)

    Google Scholar 

  20. Bruyn, G. W. (1977). Bassen-Kornzweig disease. In Vinken, P. J. and Bruyn, G. W. (eds.) Handbook of Clinical Neurology. Vol. 29, pp. 401–429. (Amsterdam: North Holland)

    Google Scholar 

  21. Herbert, P. N., Gotto, A. M. and Fredrickson, D. S. (1978). Familial lipoprotein deficiency (abetalipoproteinemia, hypobetalipoproteinemia, and Tangier disease). In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 544–588. (New York: McGraw-Hill)

    Google Scholar 

  22. Scanu, A. M. (1978). Abetalipoproteinemia and hypobetalipoproteinemia: what is the primary defect? In Kark, R. A. P., Rosenberg, R. N. and Schut, L. J. (eds.) Advances in Neurology, Vol. 21, pp. 125–130. (New York: Raven Press)

    Google Scholar 

  23. Illingworth, D. R., Connor, W. E. and Miller, R. G. (1980). Abetalipoproteinemia. Report of two cases and review of therapy. Arch. Neurol., 37, 659–662

    CAS  PubMed  Google Scholar 

  24. Steinberg, D. (1978). Phytanic acid storage disease: Refsum’s syndrome. In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 688–706. (New York: McGraw-Hill)

    Google Scholar 

  25. Steinberg, D. (1978). Evaluation of the metabolic error in Refsum’s disease: strategy and tactics. In Kark, R. A. P., Rosenberg, R. N. and Schut, L. J. (eds.) Advances in Neurology. Vol. 21, pp. 113–124. (New York: Raven Press)

    Google Scholar 

  26. Warren, L. (1967). The metabolism of sialic acids. In Aronson, S. M. and Volk, B. W. (eds.) Inborn Errors of Sphingolipid Metabolism, pp. 251–259. (Oxford: Pergamon)

    Google Scholar 

  27. Svennerholm, L. (1972). Gangliosides, isolation. In Whistler, R. L. and Bemiller, J. N. (eds.) Methods in Carbohydrate Chemistry. Vol. 4, pp. 464–474. (New York: Academic Press)

    Google Scholar 

  28. Hers, H. G. and Van Hoof, F. (1973). Lysosomes and Storage Diseases. (New York: Academic Press)

    Google Scholar 

  29. Neufeld, E. F., Lim, T. W. and Shapiro, L. J. (1975). Inherited disorders of lysosomal metabolism. Annu. Rev. Biochem., 44, 357–376

    CAS  PubMed  Google Scholar 

  30. Crome, L. and Stern, J. (1976). Inborn lysosomal enzyme deficiencies. In Blackwood, W. and Corsellis, J. A. N. (eds.) Greenfield’s Neuropathology. 3rd Edn., pp. 500–580. (London: Arnold)

    Google Scholar 

  31. Brady, R. O. (1978). Sphingolipidoses. Annu. Rev. Biochem., 47, 687–713

    CAS  PubMed  Google Scholar 

  32. O’Brien, J. S. (1978). The gangliosidoses. In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease, 4th Edn., pp. 841–865. (New York: McGraw-Hill)

    Google Scholar 

  33. Van Hoof, F. (1973). GM1 gangliosidosis. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 305–321. (New York: Academic Press)

    Google Scholar 

  34. O’Brien, J. S. (1975). Molecular genetics of GM1-galactosidase. Clin. Genet., 8, 303–313

    PubMed  Google Scholar 

  35. Farrell, D. F. and MacMartin, M. P. (1981). GM1 gangliosidosis: enzymatic variation in a single family. Ann. Neurol., 9, 232–236

    CAS  PubMed  Google Scholar 

  36. Farrell, D. F. and Ochs, U. (1981). GM1 gangliosidosis: phenotypic variation in a single family. Ann. Neurol., 9, 225–231

    CAS  PubMed  Google Scholar 

  37. Volk, B. W., Adachi, M. and Schneck, L. (1971). The gangliosidoses. In Zimmerman, H. (ed.) Progress in Neuropathology. Vol. 1, pp. 232–254. (New York: Grune and Stratton)

    Google Scholar 

  38. O’Brien, J. S. (1973). Tay-Sachs’ disease and juvenile GM2 gangliosidoses. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 323–344. (New York: Academic Press)

    Google Scholar 

  39. Srivastava, S. K. and Awasthi, Y. C. (1980). Metabolic disorders in sphingolipidoses. In Kumar, S. (ed.) Biochemistry of Brain, pp. 21–47. (Oxford: Pergamon Press)

    Google Scholar 

  40. Goldman, J. E., Katz, D., Rapin, I., Purpura, D. P. and Suzuki, K. (1981). Chronic GM1 gangliosidosis presenting as dystonia. 1. Clinical and pathological features. Ann. Neurol., 9, 465–475

    CAS  PubMed  Google Scholar 

  41. O’Brien, J. S., Bernett, J., Veath, M. L. and Paa, D. (1975). Lysosomal storage disorders. Diagnosis by ultrastructural examination of skin biopsy specimens. Arch. Neurol, 32, 592–599

    PubMed  Google Scholar 

  42. Roizin, L. and Kaufman, M. A. (1971). Dyslipidoses. In Minckler, J. (ed.) Pathology of the Nervous system. Vol. 2, pp. 1284–1314. (New York: McGraw-Hill)

    Google Scholar 

  43. Rapin, J., Suzuki, K., Suzuki, K. and Valsamis, M. P. (1976). Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship. Arch. Neurol, 33, 120–130

    CAS  PubMed  Google Scholar 

  44. Bernheimer, H., Molzer, B. and Deisenhammer, E. (1977). Sandhoff disease: ganglioside GM2 and asialo-GM2 accumulation in the cerebrospinal fluid. J. Neurochem., 29, 351–352

    CAS  PubMed  Google Scholar 

  45. Von Specht, B. U., Geiger, B., Arnon, R., Passwell, J., Keren, G., Goldman, B. and Padeh, B. (1979). Enzyme replacement in Tay-Sachs’ disease. Neurology, 29, 848–854

    Google Scholar 

  46. Sandhoff, K. and Harzer, K. (1973). Total hexosaminidase deficiency in Tay-Sachs’ disease (Variant O). In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 346–356. (New York: Academic Press)

    Google Scholar 

  47. Johnson, W. G., Chutorian, A. and Miranda, A. (1977). A new juvenile hexoseaminidase deficiency disease presenting as cerebellar ataxia. Neurology, 27, 1012–1018.

    CAS  PubMed  Google Scholar 

  48. Tsay, G. C. and Dawson, G. (1976). Oligosaccharide storage in brains from patients with fucosidosis, GM1-gangliosidosis and GM2-gangliosidosis (Sandhoff’s disease). J. Neurochem., 27, 733–740

    CAS  PubMed  Google Scholar 

  49. MacLeod, P. M., Wood, S., Jan, J. E., Applegarth, D. A. and Dolman, C. L. (1977). Progressive cerebellar ataxia, spasticity, psychomotor retardation and hexoseaminidase deficiency in a 10-year-old child: juvenile Sandhoff disease. Neurology, 27, 571–573

    CAS  PubMed  Google Scholar 

  50. O’Neill, B., Butler, A. B., Young, E., Falk, P. M. and Bass, N. H. (1978). Adult-onset GM2 gangliosidosis. Neurology, 28, 1117–1123

    PubMed  Google Scholar 

  51. Johnson, W. G. and Chutorian, A. M. (1978). Inheritance of the enzyme defect in a new hexoseaminidase deficiency disease. Ann. Neurol, 4, 399–403

    CAS  PubMed  Google Scholar 

  52. MacLaren, N. K., Max, S. R., Cornblath, M., Brady, R. O., Ozand, P. T., Campbell, J, Rennels, M., Mergner, W. J. and Garcia, J. H. (1976). GM3 gangliosidosis: a novel human sphingolipody-strophy. Pediatrics, 57, 106–110

    CAS  PubMed  Google Scholar 

  53. Tanaka, J., Garcia, J. H., Max, S. R., Viloria, J. E., Kamijo, Y., MacLaren, N. K., Cornblath, M. and Brady, R. O. (1975). Cerebral sponginess and GM3 gangliosidosis. Ultrastructure and probable pathogenesis. J. Neuropathol. Exp. Neurol, 34, 249–262

    CAS  PubMed  Google Scholar 

  54. Carter, T. P., Beblowski, D. W., Savage, M. H. and Kanfer, J. N. (1980). Human brain cerebroside β-galactosidase: deficiency of transgalactosidic activity in Krabbe’s disease. J. Neurochem., 34, 189–196

    CAS  PubMed  Google Scholar 

  55. Kint, J. A. and Carton, D. (1973). Fabry’s disease. In Hers, H. G. and Van Hoof, F. (eds.). Lysosomes and Storage Diseases, pp. 357–380. (New York: Academic Press)

    Google Scholar 

  56. Desnick, R. J., Klionsky, B. and Sweeley, C. C. (1978). Fabry’s disease (α-galactosidase A deficiency). In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 810–840. (New York: McGraw-Hill)

    Google Scholar 

  57. Grunnet, M. L. and Spilsbury, P. R. (1973). The central nervous system in Fabry’s disease. Arch. Neurol, 28, 231–234

    CAS  PubMed  Google Scholar 

  58. Sheth, K. J. and Swick, H. M. (1980). Peripheral nerve conduction in Fabry’s disease. Ann. Neurol., 7, 319–323

    CAS  PubMed  Google Scholar 

  59. Schettler, G. and Kahlke, W. (1967). Gaucher’s disease. In Schettler, G. (ed.) Lipids and Lipidosis, pp. 260–287. (Berlin: Springer)

    Google Scholar 

  60. Brady, R. O. (1978). Glucosyl ceramide lipidosis, Gaucher’s disease. In Stanbury, J. B., Wyngaarten, J. B. and Frederickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 731–746. (New York: McGraw Hill)

    Google Scholar 

  61. Nishimura, R., Omos-Lau, N., Ajmone-Marsan, C. and Barranger, J. A. (1980). Electroencephalographic findings in Gaucher’s disease. Neurology, 30, 152–159

    CAS  PubMed  Google Scholar 

  62. Robinson, D. B. and Glew, R. H. (1980). Acid phosphatase in Gaucher’s disease. Clin. Chem., 26, 371–382

    CAS  PubMed  Google Scholar 

  63. Austin, J. (1973). Metachromatic leucodystrophy (sulfatide lipidosis). In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 412–437. (New York: Academic Press)

    Google Scholar 

  64. Dulaney, J. T. and Moser, H. W. (1978). Sulfatide lipidosis: metachromatic leukodystrophy. In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 770–809. (New York: McGraw-Hill)

    Google Scholar 

  65. Farrell, D. F., MacMartin, M. P. and Clark, A. F. (1979). Multiple molecular forms of arylsulphatase A in different forms of metachromatic leucodystrophy (MLD). Neurology, 29, 16–20

    CAS  PubMed  Google Scholar 

  66. Poser, C. M. (1968). Diseases of the myelin sheath. In Minckler, J. (ed.) Pathology of the Nervous System. Vol. 1, pp. 767–821. (New York: McGraw-Hill)

    Google Scholar 

  67. Percy, A. K., Kaback, M. M. and Herndon, R. M. (1977). Metachromatic leukodystrophy: comparison of early and late onset forms. Neurology, 27, 933–941

    CAS  PubMed  Google Scholar 

  68. Haltia, T., Palo, J., Haltia, M. and Icen, A. (1980). Juvenile metachromatic leukodystrophy. Clinical, biochemical and neuropathologic studies in nine new cases. Arch. Neurol., 37, 42–46

    CAS  PubMed  Google Scholar 

  69. Buonanno, F. S., Ball, M. R., Laster, D. W., Moody, D. M. and McLean, W. T. (1978). Computed tomography in late-infantile metachromatic leukodystrophy. Ann. Neurol., 4, 43–46

    CAS  PubMed  Google Scholar 

  70. Raghavan, S. S., Gajewski, A. and Kolodny, E. H. (1981). Leukocyte sulfatidase for the reliable diagnosis of metachromatic leukodystrophy. J. Neurochem., 36, 724–731

    CAS  PubMed  Google Scholar 

  71. Suzuki, K. and Suzuki, Y. (1978). Galactosylceramide lipidoses: globoid cell leukodystrophy (Krabbe’s disease). In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 747–769. (New York: McGraw-Hill)

    Google Scholar 

  72. Philippart, M. (1978). Clinical and biochemical pathophysiology of ataxia in the sphin-golipidoses. In Kark, R. A. P., Rosenberg, R. N. and Schut, L. J. (eds.) Advances in Neurology. Vol. 21, pp. 131–149. (New York: Raven Press)

    Google Scholar 

  73. Dickerman, L. H., Kurczynski, T. W. and MacBride, R. G. (1981). The effect of psychosine upon growth of human skin fibroblasts from patients with globoid cell leukodystrophy. J. Neurol. Sci., 50, 181–190

    CAS  PubMed  Google Scholar 

  74. Austin, J. H. (1968). Globoid (Krabbe) leukodystrophy. In Minckler, J. (ed.) Pathology of the Nervous System. Vol. 1, pp. 843–858. (New York: McGraw-Hill)

    Google Scholar 

  75. Dunn, H. G., Dolman, C. L., Farrell, D. F., Tischler, B., Hasinoff, C. and Woolf, L. I. (1976). Krabbe’s leukodystrophy without globoid cells. Neurology, 26, 1035–1041

    CAS  PubMed  Google Scholar 

  76. Svennerholm, L., Vanier, M-T., Hakansson, G. and Mansson, J-E. (1981). Use of leukocytes in diagnosis of Krabbe disease and detection of carriers. Clin. Chim. Acta, 112, 333–342

    CAS  PubMed  Google Scholar 

  77. Brady, R. O. and King, F. M. (1973). Niemann-Pick’s disease. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 439–452. (New York: Academic Press)

    Google Scholar 

  78. Brady, R. O. (1978). Sphingomyelin lipidosis: Niemann-Pick disease. In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 718–730. (New York: McGraw-Hill)

    Google Scholar 

  79. Kennedy, J. F. (1976). Chemical and biochemical aspects of the glycosaminoglycans and proteoglycans in health and disease. Adv. Clin. Chem., 18, 1–101

    CAS  PubMed  Google Scholar 

  80. Lindahl, U. and Höök, M. (1978). Glycosaminoglycans and their binding to biological macromolecules. Annu. Rev. Biochem., 47, 385–417

    CAS  PubMed  Google Scholar 

  81. McKusick, V. A., Neufeld, E. F. and Kelly, T. E. (1978). The mucopolysaccharide storage diseases. In Stanbury, J. B., Wyngaarten, J. G. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 1282–1307. (New York: McGraw-Hill)

    Google Scholar 

  82. Van Hoof, F. (1973). Mucopolysaccharidoses. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 218–259. (New York: Academic Press)

    Google Scholar 

  83. Dawson, G. and Lenn, N. J. (1976). Polysaccharide metabolism disorders. In Vinken, P. J. and Bruyn, G. W. (eds.) Handbook of Clinical Neurology. Vol. 27, pp. 143–168. (Amsterdam: North Holland)

    Google Scholar 

  84. Dorfman, A. and Matalon, R. (1976). The mucopolysaccharidoses (a review). Proc. Natl. Acad. Sci, USA, 73, 630–637

    CAS  PubMed  Google Scholar 

  85. Kint, J. A., Dacremont, G., Carton, D., Orye, E. and Hooft, C. (1973). Mucopolysaccharidosis: secondarily induced abnormal distribution of lysosomal isoenzymes. Science, 181, 352–354

    CAS  PubMed  Google Scholar 

  86. Winters, P. R., Harrod, M. J., Molenich-Heetred, S. A., Kirkpatrick, J. and Rosenberg, R. N. (1976). α-L-Iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings. Neurology, 26, 1003–1007

    CAS  PubMed  Google Scholar 

  87. Nwokoro, N. and Neufeld, E. F. (1979). Detection of Hunter heterozygotes by enzymatic analysis of hair roots. Am. J. Hum. Genet., 31, 42–49

    CAS  PubMed Central  PubMed  Google Scholar 

  88. Taori, G. M., Iyer, G. V., Mokashi, S., Balasubramanian, K. A., Cherian, R., Chandi, S., Job, C. K. and Bachhawat, B. K. (1972). Sanfillipo syndrome (mucopolysaccharidosis — III). J. Neurol. Sci., 17, 323–345

    CAS  PubMed  Google Scholar 

  89. Dekaban, A. S. and Constantopoulos, G. (1977). Mucopolysaccharidosis Types I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain. Acta Neuropathol., 39, 1–7

    CAS  PubMed  Google Scholar 

  90. Constantopoulos, G., Eiben, R. M. and Schäfer, I. A. (1978). Neurochemistry of the mucopolysaccharidoses: brain glycoaminoglycans, lipids and lysosomal enzymes in mucopolysac-charoidosis type HIB (α-N-acetylglucosamidase deficiency). J. Neurochem., 31, 1215–1222

    CAS  PubMed  Google Scholar 

  91. Hadfield, M. G., Ghatak, N. R., Nakoneczna, I., Lippman, H. R., Myer, E. C., Constantopoulos, G. and Bradley, R. M. (1980). Pathologic findings in mucopolysaccharidosis type HIB (Sanfillipo’s syndrome B). Arch. Neurol., 37, 645–650

    CAS  PubMed  Google Scholar 

  92. Koto, A., Horwitz, A. L., Suzuki, K., Tiffany, C. W. and Suzuki, K. (1978). The Morquio syndrome: neuropathology and biochemistry. Ann. Neurol., 4, 26–36

    CAS  PubMed  Google Scholar 

  93. Pilz, H., Von Figura, K. and Goebel, H. H. (1979). Deficiency of arylsulfatase B in 2 brothers aged 40 and 38 years (Maroteaux-Lamy syndrome, type B). Ann. Neurol., 6, 315–325

    CAS  PubMed  Google Scholar 

  94. Sly, W. S., Quinton, B. A., McAlister, W. H. and Rimoin, D. L. (1973). Beta-glucuronidase deficiency. Report of clinical, radiologic and biochemical features of a new mucopolysaccharidosis. J. Pediatr., 82, 249–257

    CAS  PubMed  Google Scholar 

  95. Spranger, J. and Wiedermann, H. (1970). The genetic mucolipidoses. Hum. Genet., 9, 113–139

    CAS  Google Scholar 

  96. Spranger, J., Gehler, J. and Cantz, M. (1977). Mucolipidosis 1 — a sialidosis. Am. J. Med. Genet., 1, 21–29

    Google Scholar 

  97. Ockerman, P. A. (1973). Mannosidosis. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 291–304. (New York: Academic Press)

    Google Scholar 

  98. Sung, J. H., Hayano, M. and Desnick, R. J. (1977). Mannosidosis: pathology of the nervous system. J. Neuropathoi. Exp. Neurol., 36, 807–820

    CAS  Google Scholar 

  99. Van Hoof, F. (1973). Fucosidosis. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 277–290. (New York: Academic Press)

    Google Scholar 

  100. Van Hoof, F. and Hers, H. G. (1973). Other lysosomal storage disorders. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 554–573. (New York: Academic Press)

    Google Scholar 

  101. Shih, V. (1977). Miscellaneous metabolic disorders involving amino acids and organic acids. In Vinken, P. J. and Bruyn, G. W. (eds.) Handbook of Clinical Neurology. Vol. 29, pp. 195–243. (Amsterdam: North Holland)

    Google Scholar 

  102. Maury, C. P. J., Haltia, M. and Palo, J. (1981). Regional distribution of glycoasparagine storage material in the brain in aspartylglycosaminuria. J. Neurol. Sci., 50, 291–298

    CAS  PubMed  Google Scholar 

  103. Austin, J. H. (1973). Studies in metachromatic leukodystrophy. XII. Multiple sulfatase deficiency. Arch. Neurol., 28, 258–264

    CAS  PubMed  Google Scholar 

  104. Eto, Y., Meier, C. and Herschkowitz, N. N. (1976). Chemical composition of brain and myelin in two patients with multiple sulphatase deficiency (a variant from metachromatic leukodystrophy). J. Neurochem., 27, 1071–1076

    CAS  PubMed  Google Scholar 

  105. Eto, Y., Owada, M., Kitigawa, T., Kokubun, Y. and Rennert, O. M. (1979). Neurochemical abnormality in I-cell disease: chemical analysis and a possible importance of beta-galactosidase deficiency. J. Neurochem., 32, 397–405

    CAS  PubMed  Google Scholar 

  106. Miller, A. L., Levitt, P., Ingraham, H., Converse, J. and Lewis, L. (1979). Properties of acid-β-D-galactosidase isolated from I-cell disease brain and spleen. J. Neurochem., 32, 1479–1485

    CAS  PubMed  Google Scholar 

  107. Martin, J. J., Leroy, J. G., Farriaux, J. P., Fontaine, G., Desnick, R. J. and Cabello, H. (1975). I-cell disease (mucolipidosis II). A report on its pathology. Acta Neuropathol., 33, 285–305

    CAS  PubMed  Google Scholar 

  108. Lowden, J. A. and O’Brien, J. S. (1979). Sialidosis: a review of human neuramidase deficiency. Am. J. Hum. Genet., 31, 1–18

    CAS  PubMed Central  PubMed  Google Scholar 

  109. Federico, A., Cecio, A., Apponi Battim, G., Michalski, J. C., Strecker, G. and Guazzi, G. C. (1980). Macular cherry-red spot and myoclonus syndrome. Juvenile form of sialidosis. J. Neurol. Sci., 48, 157–169

    CAS  PubMed  Google Scholar 

  110. Franceschetti, S., Uziel, G., Di Donato, S., Caimi, L. and Avanzini, G. (1980). Cherry-red spot myoclonus syndrome and a-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult. J. Neurol. Neurosurg. Psychiatry., 43, 934–940

    CAS  PubMed  Google Scholar 

  111. Steinman, L., Tharp, B. R., Dorfman, L. J., Forno, L. S., Sogg, R. L., Kelts, K. A. and O’Brien, J. S. (1980). Peripheral neuropathy in the cherry-red spot-myoclonus syndrome (sialidosis type 1). Ann. Neurol., 7, 450–456

    CAS  PubMed  Google Scholar 

  112. Zeman, W. and Siakotos, A. N. (1973). The neuronal ceroid-lipofuscinoses. In Hers, H. G. and Van Hoof, F. (eds.) Lysosomes and Storage Diseases, pp. 519–551. (New York: Academic Press)

    Google Scholar 

  113. Swaiman, K. F., Garg, B. P. and Lockman, L. A. (1975). Sea-blue histiocyte and posterior column dysfunction: a familial disorder. Neurology, 25, 1064–1067

    Google Scholar 

  114. Ryan, G. B., Anderson, R. McD., Menkes, J. H. and Dennett, X. (1970). Lipofuscin (ceroid) storage disease of the brain. Neuropathological and neurochemical studies. Brain, 93, 617–628

    CAS  PubMed  Google Scholar 

  115. Jervis, G. A. and Pullarkat, R. K. (1978). Pigment variant of lipofuscinoses. Neurology, 28, 500–503

    CAS  PubMed  Google Scholar 

  116. Greenwood, R. S. and Nelson, J. S. (1978). Atypical neuronal ceroid-lipofuscinosis. Neurology, 28, 710–717

    CAS  PubMed  Google Scholar 

  117. Noonan, S. M., Desousa, J. and Riddle, J. M. (1978). Lymphocyte ultrastructure in two cases of neuronal ceroid-lipofuscinosis. Neurology, 28, 472–477

    CAS  PubMed  Google Scholar 

  118. Miley, C. E., Gilbert, E. F., France, T. D., O’Brien, J. F. and Chun, R. W. M. (1978). Clinical and extraneural histologic diagnosis of neuronal ceroid-lipofuscinosis. Neurology, 28, 1008–1012

    PubMed  Google Scholar 

  119. Pilz, H., Schwendemann, G. and Goebel, H. H. (1978). Diagnostic significance of myeloperoxidase assay in neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome). Neurology, 28, 924–927

    CAS  PubMed  Google Scholar 

  120. Schwerer, B. and Bernheimer, H. (1978). Leukocyte PPD-peroxidase activity with polyunsaturated fatty acid hydroperoxides: normal values in Batten’s disease. J. Neurochem., 31, 457–460

    CAS  PubMed  Google Scholar 

  121. Glenner, G. G., Ignaczak, T. F. and Page, D. L. (1978). The inherited systemic amyloidoses and localized amyloid deposits. In Stanbury, J. B., Wyngaarten, J. B. and Fredrickson, D. S. (eds.) The Metabolic Basis of Inherited Disease. 4th Edn., pp. 1308–1339. (New York: McGraw-Hill)

    Google Scholar 

  122. Shoji, S. and Okano, A. (1981). Amyloid fibril protein in familial amyloid polyneuropathy. Neurology, 31, 186–190

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Queensland, Brisbane, Australia

    M. J. Eadie

Authors
  1. M. J. Eadie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. H. Tyrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1983 M. J. Eadie and J. H. Tyrer

About this chapter

Cite this chapter

Eadie, M.J., Tyrer, J.H. (1983). Disorders of the metabolism of larger molecules. In: Biochemical Neurology. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0896-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-0896-8_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-0898-2

  • Online ISBN: 978-94-017-0896-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation